CA-102N

N/A

Report date: 2025/03/26 20:01:25

Base Information

Drug NameCA-102N
Drug Alias NameHA-NimesulideNim-HA ConjugateHyaluronic acid nimesulide-NH2 bioconjugateCA-102N
ClassificationSmall molecules
Mechanisms of ActionCD44 antigen inhibitorsPlatelet aggregation inhibitorsHyaluronic acid modulators +[4] 
TargetsCD44 antigenHyaluronic acid
Therapy Area/IndicationsSolid tumoursColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHoly Stone Healthcare Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHoly Stone Healthcare Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A